Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events

被引：0
|
作者：
Sara Lee
Christopher P. Cannon
机构：
[1] Temple University School of Pharmacy,Cardiovascular Division, Harvard Medical School
[2] Brigham and Women’s Hospital,undefined
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Statin therapy; PCSK9 inhibitors; Cholesterol; Cardiovascular risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Lipid-lowering therapies: Better together
    Banach, Maciej
    Penson, Peter E.
    ATHEROSCLEROSIS, 2021, 320 : 86 - 88
  • [32] Lipid-lowering drug use and cardiovascular events after myocardial infarction
    Klungel, OH
    Heckbert, SR
    de Boer, A
    Leufkens, HGM
    Sullivan, SD
    Fishman, PA
    Veenstra, DL
    Psaty, BM
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) : 751 - 757
  • [33] Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events
    Raggi, Paolo
    Becciu, Maria Laura
    Navarese, Eliano P.
    CURRENT OPINION IN LIPIDOLOGY, 2024, 35 (03) : 110 - 116
  • [34] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [35] Lipid-lowering treatments and cardiovascular prevention in diabetic subjects: news and perspectives
    Valero, Rene
    Beliard, Sophie
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2018, 22 (3-4): : 84 - 89
  • [36] Choosing lipid-lowering statin in risk strategy of cardiovascular event prevention
    Yvleva, A. Ya.
    Alekseeva, L. A.
    Poluboyarova, N. M.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 54 - +
  • [37] Lipid-Lowering Therapy with Statins for the Primary and Secondary Prevention of Cardiovascular Disease
    Lardizabal, Joel A.
    Deedwania, Prakash
    CARDIOLOGY CLINICS, 2011, 29 (01) : 87 - +
  • [38] Initiation of lipid-lowering therapy as primary prevention of cardiovascular disease in the elderly
    Vinuesa-Hernando, Jose Manuel
    Aguilar-Palacio, Isabel
    Rabanaque, Maria Jose
    Garcia-Cardenas, Victoria
    Lallana, Maria Jesus
    Gamba, Adriana
    Malo, Sara
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [39] Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the ElderlyOpportunities and Challenges
    Jennifer G. Robinson
    Drugs & Aging, 2009, 26 : 917 - 931
  • [40] Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
    Daniel Tobias Michaeli
    Julia Caroline Michaeli
    Sebastian Albers
    Tobias Boch
    Thomas Michaeli
    American Journal of Cardiovascular Drugs, 2023, 23 : 477 - 495
12345